Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Catalyst Biosciences Inc.

    NASDAQ: CBIO · Real-Time Price · USD
    0.51
    -0.02 (-2.89%)
    At close: Oct 30, 2023, 8:00 PM

    Catalyst Biosciences Statistics

    Share Statistics

    Catalyst Biosciences has 37.98M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 37.98M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 141,195

    FTD / Avg. Volume

    n/a
    		 32.29%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -2.02 and the forward PE ratio is null. Catalyst Biosciences's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -2.02

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 20.96

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -0.77

    P/FCF Ratio

    n/a
    		 -0.5

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Catalyst Biosciences has an Enterprise Value (EV) of -4.99M.

    EV / Sales

    n/a
    		 -6.28

    EV / EBITDA

    n/a
    		 0.1

    EV / EBIT

    n/a
    		 0.15

    EV / FCF

    n/a
    		 0.15

    Financial Position

    The company has a current ratio of 1.68, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 1.68

    Quick Ratio

    n/a
    		 1.68

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -12.01

    Financial Efficiency

    Return on Equity is 38% and Return on Invested Capital is 41.53%.

    Return on Equity

    n/a
    		 38%

    Return on Assets

    n/a
    		 -28.98%

    Return on Invested Capital

    n/a
    		 41.53%

    Revenue Per Employee

    n/a
    		 $113,428.57

    Profits Per Employee

    n/a
    		 $-1,177,428.57

    Employee Count

    n/a
    		 7

    Asset Turnover

    n/a
    		 0.03

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 348K

    Effective Tax Rate

    n/a
    		 -4.41%

    Stock Price Statistics

    The stock price has increased by -0.25% in the last 52 weeks. The beta is 1.29, so Catalyst Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.29

    52-Week Price Change

    n/a
    		 -0.25%

    50-Day Moving Average

    n/a
    		 0.5

    200-Day Moving Average

    n/a
    		 0.33

    Relative Strength Index (RSI)

    n/a
    		 55.25

    Average Volume (20 Days)

    n/a
    		 437,269

    Income Statement

    In the last 12 months, Catalyst Biosciences had revenue of 794K and earned -8.24M in profits. Earnings per share was -0.26.

    Revenue

    n/a
    		 794K

    Gross Profit

    n/a
    		 -4K

    Operating Income

    n/a
    		 -8.61M

    Net Income

    n/a
    		 -8.24M

    EBITDA

    n/a
    		 -52.15M

    EBIT

    n/a
    		 -7.18M

    Earnings Per Share (EPS)

    n/a
    		 -0.26
    Full Income Statement

    Balance Sheet

    The company has 21.67M in cash and 38K in debt, giving a net cash position of 21.63M.

    Cash & Cash Equivalents

    n/a
    		 21.67M

    Total Debt

    n/a
    		 38K

    Net Cash

    n/a
    		 21.63M

    Retained Earnings

    n/a
    		 -410.94M

    Total Assets

    n/a
    		 n/a

    Working Capital

    n/a
    		 n/a
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -33.1M and capital expenditures 0, giving a free cash flow of -33.1M.

    Operating Cash Flow

    n/a
    		 -33.1M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -33.1M

    FCF Per Share

    n/a
    		 -1.05
    Full Cash Flow Statement

    Margins

    Gross margin is -0.5%, with operating and profit margins of -1084.51% and -1038.04%.

    Gross Margin

    n/a
    		 -0.5%

    Operating Margin

    n/a
    		 -1084.51%

    Pretax Margin

    n/a
    		 -994.21%

    Profit Margin

    n/a
    		 -1038.04%

    EBITDA Margin

    n/a
    		 -6568.39%

    EBIT Margin

    n/a
    		 -1084.51%

    FCF Margin

    n/a
    		 -4168.26%

    Dividends & Yields

    CBIO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -49.53%

    FCF Yield

    n/a
    		 -198.89%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for CBIO.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 31, 2023. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Oct 31, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 n/a

    Piotroski F-Score

    n/a
    		 n/a

    Add to Watchlist